Semus Wealth Partners LLC Grows Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Semus Wealth Partners LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 784 shares of the medical equipment provider’s stock after purchasing an additional 27 shares during the period. Semus Wealth Partners LLC’s holdings in Intuitive Surgical were worth $385,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Capital World Investors grew its holdings in Intuitive Surgical by 1.0% during the first quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after acquiring an additional 73,634 shares during the period. Baillie Gifford & Co. lifted its position in shares of Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. American Century Companies Inc. lifted its position in Intuitive Surgical by 3.0% during the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock worth $1,066,837,000 after buying an additional 70,556 shares in the last quarter. Clearbridge Investments LLC raised its position in Intuitive Surgical by 1.6% in the second quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock valued at $881,380,000 after purchasing an additional 30,449 shares during the period. Finally, Assenagon Asset Management S.A. raised its position in Intuitive Surgical by 15.4% in the second quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock valued at $659,893,000 after purchasing an additional 197,841 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Jamie Samath sold 269 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 91,178 shares of company stock worth $45,897,071. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.1 %

NASDAQ ISRG opened at $528.00 on Monday. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $544.38. The company has a market capitalization of $188.06 billion, a PE ratio of 84.82, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The firm’s fifty day simple moving average is $499.29 and its 200-day simple moving average is $458.50.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on ISRG shares. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Raymond James increased their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Finally, Citigroup raised their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $524.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.